Nuvaira Stock

nuvaira.comHealthcareFounded: 2008Funding to Date: $150.32MM

Nuvaira is a medical device company that develops therapies to improve outcomes for patients suffering from obstructive lung diseases by addressing underlying disease pathophysiology.

Register for Details

For more details on financing and valuation for Nuvaira, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Nuvaira.

Register Today


Management Team

Dennis Wahr MD
President, Chief Executive Officer and Board Member
Lorraine Marshall Wright
Senior Marketing Consultant
Jim Pavliska
Vice President of Clinical Affairs
Kari Golembeck Kubesh
Chief Financial Officer
Joseph Ostendorg
Regulatory Affairs & Quality Systems Manager
Martin Mayse MD
Chief Technology Officer & Co-Founder
Shane Gleason
Chief Commercial Officer
Mahtab Fatemi JD
Vice President, Regulatory Affairs & Quality

Board Members

Christopher Shen MD
Qiming Venture Partners
Jonathan Root MD
US Venture Partners
Kirk Nielsen
Versant Venture Management
Carolyn Ng Ph.D
Vertex Ventures HC
Henry Plain Jr.
Morgenthaler Ventures
Mark Deem
Lightstone Ventures
David Stassen
Split Rock Partners
James Lee Tze Wei
Alexander Schmitz
Endeavour Vision
Michael Carusi
Advanced Technology Ventures

Other companies like Nuvaira in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


Minneapolis, Minnesota-based Nuvaira has raised $79 million in funding to further develop its novel therapeutic medical devices for treating obstructive lung diseases.